abstract |
This invention relates to compounds of general formula I n n n n n n n n n n in which R 1 and R 2 are described in this application, the use of the compounds of general formula I as inhibitors of protein tyrosine kinases for treatment of various diseases as well as the compounds of general formulas II and III n n n n n n n n n n as intermediate compounds for the production of compounds of general formula I, whereby X, R 1a and R 2a have the meaning that is described in general formulas II and III. |